BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28824332)

  • 1. Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.
    Haraldsson S; Klarskov L; Nilbert M; Bernstein I; Bonde J; Holck S
    BMC Clin Pathol; 2017; 17():11. PubMed ID: 28824332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM; Zhu XZ; Ji Y; Hou J
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.
    Dominguez-Valentin M; Therkildsen C; Veerla S; Jönsson M; Bernstein I; Borg A; Nilbert M
    PLoS One; 2013; 8(8):e71755. PubMed ID: 23951239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.
    Therkildsen C; Jönsson G; Dominguez-Valentin M; Nissen A; Rambech E; Halvarsson B; Bernstein I; Borg K; Nilbert M
    Eur J Cancer; 2013 Apr; 49(6):1226-35. PubMed ID: 23245329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.
    Klarskov L; Holck S; Bernstein I; Nilbert M
    J Clin Pathol; 2012 Apr; 65(4):352-6. PubMed ID: 22287689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Colorectal Cancer Type X (FCCTX) and the correlation with various genes-A systematic review.
    Nejadtaghi M; Jafari H; Farrokhi E; Samani KG
    Curr Probl Cancer; 2017; 41(6):388-397. PubMed ID: 29096939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
    Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain.
    Medina-Arana V; Rahy-Martín A; Delgado-Plasencia L; Martínez-Riera A; León-Ayllón D; Rodríguez-Castellano D; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera JJ
    Colorectal Dis; 2016 Nov; 18(11):O388-O396. PubMed ID: 27671100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.
    Walsh MD; Cummings MC; Pearson SA; Clendenning M; Walters RJ; Nagler B; Hopper JL; Jenkins MA; Suthers GK; Goldblatt J; Tucker K; Gattas MR; Arnold JL; Parry S; Macrae FA; McGuckin MA; Young JP; Buchanan DD
    Mod Pathol; 2013 Jul; 26(7):944-54. PubMed ID: 23370770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees.
    Xu Y; Li C; Zhang Y; Guo T; Zhu C; Xu Y; Liu F
    Front Oncol; 2020; 10():1603. PubMed ID: 32984025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
    Shiovitz S; Copeland WK; Passarelli MN; Burnett-Hartman AN; Grady WM; Potter JD; Gallinger S; Buchanan DD; Rosty C; Win AK; Jenkins M; Thibodeau SN; Haile R; Baron JA; Marchand LL; Newcomb PA; Lindor NM;
    Br J Cancer; 2014 Jul; 111(3):598-602. PubMed ID: 24918813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.
    Sánchez-Tomé E; Rivera B; Perea J; Pita G; Rueda D; Mercadillo F; Canal A; Gonzalez-Neira A; Benitez J; Urioste M
    J Gastroenterol; 2015 Jun; 50(6):657-66. PubMed ID: 25381643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer.
    Chen CH; Sheng Jiang S; Hsieh LL; Tang R; Hsiung CA; Tsai HJ; Chang IS
    Clin Transl Gastroenterol; 2016 Dec; 7(12):e208. PubMed ID: 27977020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
    Cathro HP; Mills SE
    Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic Pitfall.
    Neri G; Arpa G; Guerini C; Grillo F; Lenti MV; Giuffrida P; Furlan D; Sessa F; Quaquarini E; Viglio A; Ubezio C; Pasini A; Ferrero S; Sampietro G; Ardizzone S; Latella G; Mescoli C; Rugge M; Zingone F; Barresi V; Ciccocioppo R; Pedrazzoli P; Corazza GR; Luinetti O; Solcia E; Paulli M; Di Sabatino A; Vanoli A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
    Choi YH; Lakhal-Chaieb L; Kröl A; Yu B; Buchanan D; Ahnen D; Le Marchand L; Newcomb PA; Win AK; Jenkins M; Lindor NM; Briollais L
    J Natl Cancer Inst; 2019 Jul; 111(7):675-683. PubMed ID: 30380125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.